A Phase 1 Study of ATORM-C in Patients With Crohn's Disease | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Phase 1 Study of ATORM-C in Patients With Crohn's Disease | stella

Back to Crohn's Diseases trials

Recruiting

Plain-English translation of NCT07822087 on ClinicalTrials.gov ↗ · Source last updated September 2026 · How we translate trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

South Korea

Asan Medical Center, Seoul

Key details

Phase

Safety & dosing

Sponsor

ORGANOIDSCIENCES LTD.

Enrollment target

~18 participants

Started

September 2026

Primary completion

August 2028

Age range

19 Years – 80 Years

Last updated on clinicaltrials.gov in September 2026.

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.